Radojka M Savic Selected Research

rifapentine (Priftin)

1/2021	Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
1/2021	Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis.
1/2020	Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection.
1/2018	Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.
1/2016	A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
2/2015	Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
1/2015	Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
6/2014	Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.
6/2014	Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Radojka M Savic Research Topics

Disease

19	Tuberculosis (Tuberculoses) 11/2022 - 06/2014
8	Pulmonary Tuberculosis 01/2022 - 06/2008
6	Infections 01/2022 - 01/2019
5	Malaria 01/2022 - 01/2018
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 11/2022 - 01/2019
3	HIV Infections (HIV Infection) 11/2022 - 10/2018
3	Body Weight (Weight, Body) 10/2018 - 11/2013
2	Lung Diseases (Lung Disease) 01/2022 - 01/2018
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2022
2	Gout 01/2021 - 09/2012
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2017
2	COVID-19 12/2020 - 01/2020
2	Parasitemia 11/2020 - 01/2018
2	Latent Tuberculosis 01/2020 - 06/2014
2	Neoplasms (Cancer) 09/2017 - 03/2005
1	Meningeal Tuberculosis (Tuberculous Meningitis) 02/2022
1	Malnutrition (Nutritional Deficiencies) 02/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Hemolytic Anemia 01/2022
1	Anemia 01/2022
1	Hemolysis 01/2022
1	Ototoxicity 01/2021
1	Cough 01/2021
1	Tics (Tic) 01/2020
1	Granuloma 01/2020
1	Multiple Sclerosis 10/2017
1	Triple Negative Breast Neoplasms 09/2017
1	Hypersensitivity (Allergy) 01/2015
1	Epilepsy (Aura) 06/2012
1	Nocturnal Enuresis (Bedwetting) 10/2006

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 03/2022 - 06/2014
11	Rifampin (Rifampicin)FDA LinkGeneric 11/2022 - 06/2008
9	rifapentine (Priftin)FDA Link 01/2021 - 06/2014
7	Pyrazinamide FDA LinkGeneric 01/2021 - 02/2015
6	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 06/2014
5	Moxifloxacin (Avelox)FDA Link 03/2022 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
3	piperaquineIBA 01/2022 - 01/2018
3	artenimol (dihydroartemisinin)IBA 01/2022 - 01/2018
3	Ethambutol (Myambutol)FDA LinkGeneric 01/2021 - 02/2015
2	voxelotorIBA 01/2022 - 01/2022
2	Sickle HemoglobinIBA 01/2022 - 01/2022
2	Oxypurinol (Oxipurinol)IBA 01/2021 - 09/2012
2	Azithromycin (Zithromax)FDA LinkGeneric 12/2020 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 01/2020
2	Chloroquine (Aralen)FDA LinkGeneric 12/2020 - 01/2020
2	RifamycinsIBA 01/2018 - 01/2015
2	Cladribine FDA LinkGeneric 10/2017 - 03/2005
1	Tenofovir (Viread)FDA Link 11/2022
1	Emtricitabine (Emtriva)FDA Link 11/2022
1	bedaquiline (R207910)IBA 11/2022
1	MacrolidesIBA 01/2022
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	AminoglycosidesIBA 01/2021
1	AcidsIBA 01/2021
1	Allopurinol (Remid)FDA LinkGeneric 01/2021
1	Amikacin (A.M.K)FDA LinkGeneric 01/2021
1	thiamine triphosphorate (TTP)IBA 01/2021
1	Kanamycin FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	quinolineIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	TabletsIBA 01/2019
1	Levofloxacin (Levaquin)FDA Link 01/2019
1	FluoroquinolonesIBA 01/2019
1	Gatifloxacin (Zymar)FDA Link 01/2019
1	efavirenz (Sustiva)FDA Link 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2017
1	PlatinumIBA 09/2017
1	A-Form DNA (A-DNA)IBA 09/2017
1	Carboplatin (JM8)FDA LinkGeneric 09/2017
1	veliparibIBA 09/2017
1	Antitubercular AgentsIBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	Busulfan (Busulfex)FDA Link 11/2013
1	Gabapentin (Neurontin)FDA LinkGeneric 06/2012
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2006
1	Dosage Forms (Dosage Form)IBA 10/2006
1	NucleosidesIBA 03/2005

Therapy/Procedure

6	Duration of Therapy 01/2022 - 06/2014
3	Therapeutics 10/2021 - 10/2018
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2015
2	Chemoprevention 01/2022 - 11/2020
1	Injections 01/2021